IND Evaluation

JRF is an independent, non-profit, scientific foundation

JRF Global’s IND-enabling safety evaluation encompasses a wide range of services in mammalian toxicology, genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. JRF’s scientific teams have many years of experience in conducting the preclinical studies, focusing on proving the safety and efficacy of the compounds to convince the FDA or other drug regulatory body to allow a clinical trial to proceed. Our teams, led by Ph.D. scientists and internationalconsultants provide guidance to support your IND submissions. Many of our customers have successfully submitted their INDs to FDA, EMA and other regulatory bodies.

JRF’s accelerated IND reports:

Timelines are the most critical phases for the IND submissions and hence, JRF Global has adopted innovative standardized system of accelerated IND summary reports as well as audited draft reports in order to enable you to plan your submissions in advance.

IND enabling Safety Evaluation studies: